The Faculty of Medicine

Fighting the Corona Virus – New Research Grants

The Faculty of Medicine Congratulate researchers receiving competitive grants to accelerate the fight against the Corona Virus

Dr. Alex Rouvinski, Prof. Ilan Roseenshine & Hanah Margalit from the Department of Microbiology and Human Genetics, IMR and Dr. Reuven Wiener from the Department for Biochemistry and Molecular Biology; The Institute for Medical Research Israel-Canada (IMRIC) for the research entitled: Massive Parallel Serological Testing to Identify Individuals Immune to SARS COV 2; Ministry of Sciences and Technology.

Dr. Yuval Tabach from the Department of Developmental Biology and Cancer Research, The Institute for Medical Research Israel-Canada (IMRIC) for the research entitled: Systematic computational drug repositioning to treat COVID-19; Israel Innovation Authority

Prof. Moshe Kotler & Prof. Eli Pikarsky from the Department of Immunology and Cancer Research, The Institute for Medical Research Israel-Canada (IMRIC) in collaboration with Prof. Itamar Willner (Faculty of Natural Sciences) for the research entitled: Development of fillers/matrices for the active neutralization of pathogens/viruses for application in masks and ventilation systems; Israel Innovation Authority

Prof. Raymond Kaemper from the Department for Biochemistry and Molecular Biology; The Institute for Medical Research Israel-Canada (IMRIC) for the research entitled: Broad Spectrum Host-Oriented Therapy for Military BW Threats; The Milgrom Family Fund in Military Medicine

Dr. Lior Nissim from the Department for Biochemistry and Molecular Biology; The Institute for Medical Research Israel-Canada (IMRIC) in collaboration with the Israel Institute for Biological Research (IIBR) for the research entitled: Developing mouse COVID-19 model; The Milner foundation

Dr. Lior Nissim from the Department for Biochemistry and Molecular Biology; The Institute for Medical Research Israel-Canada (IMRIC) in collaboration with Prof. Amiram Goldblum, School of Pharmacy, Faculty of Medicine, HU; for the research entitled: Screening for anti SARS-2 drugs; HUJI research and development authority